Effect of Semaglutide on Healing of Foot Ulcers in Type 2 Diabetes Patients
The aim of this exploratory pilot study is to investigate the effect of semaglutide compared to placebo on healing of foot ulcers in type 2 diabetes patients. It is a randomized double blind, placebo controlled, clinical intervention study of 20 weeks intervention.
Diagnosis of type 2 diabetes mellitus for at least 6 months [+3]
Current use, or recent use (<3 months), of GLP-1 agonists [+27]